JP2010530846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530846A5 JP2010530846A5 JP2010510365A JP2010510365A JP2010530846A5 JP 2010530846 A5 JP2010530846 A5 JP 2010530846A5 JP 2010510365 A JP2010510365 A JP 2010510365A JP 2010510365 A JP2010510365 A JP 2010510365A JP 2010530846 A5 JP2010530846 A5 JP 2010530846A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- mol
- reducing sugar
- reducing
- histidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94155607P | 2007-06-01 | 2007-06-01 | |
| US96908007P | 2007-08-30 | 2007-08-30 | |
| PCT/US2008/006898 WO2008150479A2 (en) | 2007-06-01 | 2008-05-29 | High temperature stable peptide formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010530846A JP2010530846A (ja) | 2010-09-16 |
| JP2010530846A5 true JP2010530846A5 (https=) | 2012-07-19 |
Family
ID=40094334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510365A Pending JP2010530846A (ja) | 2007-06-01 | 2008-05-29 | 高温で安定なペプチド製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7879805B2 (https=) |
| EP (1) | EP2150537A4 (https=) |
| JP (1) | JP2010530846A (https=) |
| AU (1) | AU2008260483A1 (https=) |
| CA (1) | CA2687246A1 (https=) |
| MX (1) | MX2009012964A (https=) |
| WO (1) | WO2008150479A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2952522B1 (en) | 2007-01-31 | 2019-10-30 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| AU2008232709C1 (en) | 2007-03-28 | 2015-01-15 | President And Fellows Of Harvard College | Stitched polypeptides |
| US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
| WO2010062896A1 (en) * | 2008-11-28 | 2010-06-03 | Abbott Laboratories | Stable antibody compositions and methods for stabilizing same |
| MX2011011772A (es) * | 2009-05-04 | 2012-02-08 | Abbott Biotech Ltd | Formulaicones estables de anticuerpos humanos anti-tnf-alfa con alta concentracion de proteina. |
| SG10201407724YA (en) * | 2009-11-23 | 2014-12-30 | Cubist Pharm Inc | Daptomycin compositions and related methods |
| HUE026885T2 (en) | 2010-03-31 | 2016-08-29 | Stabilitech Ltd | Stabilize virus fragments |
| EP2552410B1 (en) * | 2010-03-31 | 2018-10-24 | Stabilitech Biopharma Ltd | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| BR112012025047A2 (pt) | 2010-03-31 | 2016-06-21 | Stabilitech Ltd | formulações líquidas estabilizadas |
| KR20170058446A (ko) | 2010-08-13 | 2017-05-26 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| SG190069A1 (en) | 2010-11-11 | 2013-06-28 | Abbvie Biotechnology Ltd | IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS |
| CN102488889B (zh) * | 2011-09-26 | 2014-01-22 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| CN103315969B (zh) * | 2011-09-26 | 2016-05-18 | 上海天伟生物制药有限公司 | 一种低杂质含量的卡泊芬净制剂及其制备方法和用途 |
| GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
| AR088392A1 (es) | 2011-10-18 | 2014-05-28 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos |
| WO2013066795A1 (en) * | 2011-11-02 | 2013-05-10 | The University Of Chicago | Stable pharmaceutical formulations of growth factor peptides |
| CA2862038C (en) | 2012-02-15 | 2021-05-25 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| HK1205454A1 (en) | 2012-02-15 | 2015-12-18 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| SG11201405578TA (en) * | 2012-03-09 | 2014-11-27 | Oncotherapy Science Inc | Pharmaceutical composition containing peptide |
| JP6148487B2 (ja) * | 2012-05-31 | 2017-06-14 | 久保木 芳徳 | チタン−タンパク質複合体の製造方法 |
| EP2698162A1 (en) * | 2012-08-15 | 2014-02-19 | Credentis AG | Method for producing a composition for treating a tooth lesion |
| BR112015009470A2 (pt) | 2012-11-01 | 2019-12-17 | Aileron Therapeutics Inc | aminoácidos dissubstituídos e seus métodos de preparação e uso |
| US10251935B2 (en) | 2012-11-28 | 2019-04-09 | Nono Inc. | Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose |
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| WO2015181756A1 (en) | 2014-05-28 | 2015-12-03 | Nono Inc. | Chloride salt of tat-nr2b9c |
| SG11201702175YA (en) * | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
| WO2016049359A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| JP2018528217A (ja) | 2015-09-10 | 2018-09-27 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子 |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| CN109528761A (zh) * | 2018-12-20 | 2019-03-29 | 江西润泽药业有限公司 | 制备钠钾钙镁葡萄糖注射液的方法 |
| AU2021233893A1 (en) | 2020-03-12 | 2022-08-25 | Baxter Healthcare Sa | Daptomycin formulations containing a combination of sorbitol and mannitol |
| WO2021202577A1 (en) * | 2020-03-31 | 2021-10-07 | 3-D Matrix, Ltd. | Sterilization of self-assembling peptides by irradiation |
| KR102869156B1 (ko) * | 2021-03-29 | 2025-10-15 | (주)아모레퍼시픽 | 콜라겐 펩티드 안정화용 조성물 및 이를 포함하는 식품 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372716B1 (en) * | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
| US6685940B2 (en) * | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
| US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
| US5763401A (en) * | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
| AUPO871997A0 (en) * | 1997-08-25 | 1997-09-18 | Csl Limited | Dried biologically or therapeutically active preparations |
| GB9930882D0 (en) | 1999-12-30 | 2000-02-23 | Nps Allelix Corp | GLP-2 formulations |
| US6689353B1 (en) * | 2000-06-28 | 2004-02-10 | Bayer Pharmaceuticals Corporation | Stabilized interleukin 2 |
| JP2003055257A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第ｘｉｉｉ因子製剤 |
| CA2473182A1 (en) * | 2002-02-08 | 2003-08-14 | Acologix, Inc. | Compositions and methods for treatment of vitamin d deficiency |
| US20040105778A1 (en) * | 2002-10-04 | 2004-06-03 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
| US20060008415A1 (en) * | 2004-06-25 | 2006-01-12 | Protein Design Labs, Inc. | Stable liquid and lyophilized formulation of proteins |
| PT1778723E (pt) * | 2004-08-17 | 2013-01-25 | Regeneron Pharma | Formulações de antagonista de il-1 |
-
2008
- 2008-05-29 JP JP2010510365A patent/JP2010530846A/ja active Pending
- 2008-05-29 MX MX2009012964A patent/MX2009012964A/es active IP Right Grant
- 2008-05-29 WO PCT/US2008/006898 patent/WO2008150479A2/en not_active Ceased
- 2008-05-29 US US12/129,504 patent/US7879805B2/en not_active Expired - Fee Related
- 2008-05-29 CA CA002687246A patent/CA2687246A1/en not_active Abandoned
- 2008-05-29 AU AU2008260483A patent/AU2008260483A1/en not_active Abandoned
- 2008-05-29 EP EP08768001A patent/EP2150537A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010530846A5 (https=) | ||
| JP2007262090A5 (https=) | ||
| JP2011506530A5 (https=) | ||
| JP2011505522A5 (https=) | ||
| JP2011088897A5 (https=) | ||
| TWD123746S1 (zh) | 繃帶 | |
| CL2013001586A1 (es) | Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion. | |
| JP2013510216A5 (https=) | ||
| JP2013507408A5 (https=) | ||
| JP2009017880A5 (https=) | ||
| JP2011528897A5 (https=) | ||
| JP2011526526A5 (https=) | ||
| JP2006342148A5 (https=) | ||
| JP2009242695A5 (https=) | ||
| JP2010030903A5 (https=) | ||
| WO2010098625A3 (ko) | 약제학적 제제 | |
| Yip | Eco-city: From Concept to Implementation-Case Studies in Shanghai Dongtan and Beijing Changxindian | |
| JP2008143899A5 (https=) | ||
| JP2007119348A5 (https=) | ||
| Levine | Today is a new day | |
| Szurman | Triamcinolone as adjunct to vitreous surgery | |
| Sapna | Small-Pox: Remedies and diagnosis | |
| 申美花 | The Historic Study of Morphology in Korean | |
| 夏增强 | Reflections On Christianity | |
| 明风 | oaching the oaches |